At a glance
- Originator Schering-Plough
- Class Antihypertensives; Antiplatelets
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension; Vascular restenosis
Most Recent Events
- 22 Feb 2000 No-Development-Reported for Hypertension in USA (PO)
- 22 Feb 2000 No-Development-Reported for Vascular restenosis in USA (PO)
- 06 Mar 1997 New profile